Section: Partnerships and Cooperations

International Initiatives

Inria International Labs

LIRIMA

Associate Team involved in the International Lab:

SIMERGE

• Title: Statistical Inference for the Management of Extreme Risks and Global Epidemiology

• International Partner (Institution - Laboratory - Researcher):

  • UGB (Senegal) - LERSTAD - Abdou Kâ Diongue

• Start year: 2015

• See also: http://mistis.inrialpes.fr/simerge

• The objective of the associate team is to federate some researchers from LERSTAD (Laboratoire d’Etudes et de Recherches en Statistiques et Développement, Université Gaston Berger) and Mistis (Inria Grenoble Rhône-Alpes). The associate team will consolidate the existing collaborations between these two laboratories. Since 2010, the collaborations have been achieved through the co-advising of two PhD theses.They have led to three publications in international journals. The associate team will also involve statisticians from EQUIPPE laboratory (Economie QUantitative Intégration Politiques Publiques Econométrie, Université de Lille) and associated members of Modal (Inria Lille Nord-Europe) as well as an epidemiologist from IRD (Institut de Recherche pour le Développement) at Dakar. We aim at developing two research themes: 1) Spatial extremes with application to management of extreme risks and 2) Classification with application to global epidemiology.

Inria International Partners

Informal International Partners

The context of our research is also the collaboration between mistis and a number of international partners such as the Statistics Department of University of Washington in Seattle, the Russian Academy of Science in Moscow, and more recent partners like IDIAP involved in the past HUMAVIPS project, Université Gaston Berger in Senegal and Universities of Melbourne and Brisbane in Australia. We also work at turning other current European contacts, e.g. at EPFL (A. Roche at University Hospital Lausanne and Siemens Healthcare), into more formal partnerships.

The main international collaborations that we are currently trying to develop are with:

• Fabrizio Durante, Free University of Bozen-Bolzano, Italy.

• K. Qin and D. Wraith from RMIT in Melbourne, Australia and Queensland University of Technology in Brisbane, Australia.

• E. Deme and S. Sylla from Gaston Berger university and IRD in Senegal.

• Alexandre Nazin and Russian Academy of Science in Moscow, Russia.

• Alexis Roche and University Hospital Lausanne/Siemens Healthcare, Advanced Clinical Imaging Technology group, Lausanne, Switzerland.